Teva Pharmaceutical Industries - PDFSEARCH.IO - Document Search Engine

Teva Pharmaceutical Industries
Results: 58

#	Item
1	January 8, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Baxalta, Symphogen Ink $1.6 Billion ImmunoOncology Deal In yet Add to Reading List Source URL: www.dcat.org Language: English - Date: 2016-01-11 11:16:23 Business Biotechnology Economy Pharmacy Pharmaceutical industry Pharmaceuticals policy Biopharmaceutical Pharmaceutical industry in India Novartis Biosimilar Boehringer Ingelheim Teva Pharmaceutical Industries
2	December 4, 2015 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum 1. Teva, Takeda Form Generics Joint Venture in Japan Teva Pharmaceu Add to Reading List Source URL: www.dcat.org Language: English - Date: 2016-01-05 08:55:58 Business Economy Pharmaceutical sciences Pharmaceuticals policy Pharmacy Pharmaceutical industry CAC 40 Sanofi Novartis Hikma Pharmaceuticals Teva Pharmaceutical Industries Adalimumab
3	Marketing authorisations which are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation as adopted by the CHMP on 21 July 2016 Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2016-07-22 09:17:34 Chemistry Business Organic chemistry Combination drugs Ethers Amines Erlotinib Pfizer Quinazolines Teva Pharmaceutical Industries Atovaquone/proguanil Novartis
4	LEGAL NOTICE and TERMS OF USE Teva Respiratory, LLC (“Teva Respiratory”) maintains the sites www.ProAirHFA.com and www.MyProAir.com, and www.ProAir.com (the "sites") for your personal information, education, and comm Add to Reading List Source URL: www.proair.com Language: English - Date: 2016-06-17 15:42:12 Economy Business Science and technology in Israel RTT Chemistry Teva Pharmaceutical Industries Indemnity Salbutamol
5	Statement of the Federal Trade Commission In the Matter of Teva Pharmaceuticals Industries Ltd. and Allergan plc Add to Reading List Source URL: www.ftc.gov Language: English Business Economy Pharmaceuticals policy Health Science and technology in Israel Teva Pharmaceutical Industries Allergan Plc Generic drug Mergers and acquisitions Pharmaceutical industry in China Drug Price Competition and Patent Term Restoration Act Food and Drug Administration
6	REGISTER FOR APPROVED HUMAN MEDICINES JUNE 2016 UPDATE GENERIC NAME FORM DEXTROSE MONOHYDRATE OR ANHYDROUS INFUSIONS Add to Reading List Source URL: www.mcaz.co.zw Language: English - Date: 2016-07-04 06:21:42 CNX Nifty Science and technology in Israel Teva Pharmaceutical Industries Mylan Intas Biopharmaceuticals Ranbaxy Laboratories PVT
7	April 8, Pfizer and Allergan Terminate $160 Billion Merger; New US Treasury Department Action at Play Pfizer and Allergan have called off their proposed $160 billion merger citing the US Depart Add to Reading List Source URL: www.dcat.org Language: English - Date: 2016-04-08 15:57:35 American brands Pharmacy Specialty drugs Biotechnology Allergan Plc Hospira Pfizer WuXi PharmaTech Biopharmaceutical AstraZeneca Infliximab Teva Pharmaceutical Industries
8	imap AN IMAP INDUSTRY REPORT GLOBAL M&A REPORT Add to Reading List Source URL: www.kurmannpartners.com Language: English - Date: 2016-03-16 06:35:36 American brands CNX Nifty S&P/TSX Composite Index Allergan Plc Actavis Teva Pharmaceutical Industries Valeant Pharmaceuticals Sun Pharmaceutical Pfizer Mylan Perrigo AstraZeneca
9	TEVA PHARMACEUTICAL INDUSTRIES LIMITED Notice of Special Meeting of Shareholders October 1, 2015 Dear Shareholder, Add to Reading List Source URL: tevapharm.com Language: English
10	4 strategic archetypes for pharma companies DEAL DRIVERS DEALS INPipeline deals Add to Reading List Source URL: www.kurmannpartners.com Language: English - Date: 2016-03-16 06:29:23 Business Economy Pharmaceutical industry CNX Nifty BSE SENSEX Sun Pharmaceutical Novartis Mylan Sanofi Teva Pharmaceutical Industries Mergers and acquisitions Pfizer

UPDATE